Related by context. Frequent words. (Click for all words.) 72 R sorafenib tablets 71 Idera Pharmaceuticals develops 71 oncolytic virus therapies 70 Completes Patient Enrollment 70 Auxilium transmucosal film 69 candidate ridaforolimus 69 Initiates Phase II 68 sorafenib tablets 68 Currently RegeneRx 68 topical non steroidal 67 VEGFR2 inhibitor 67 Emergent marketed 67 using BioSante patented 67 orBec ® oral beclomethasone 67 addressing idiopathic pulmonary 67 topical anti infective 67 include bioavailability enhancement 67 signal detection CTSD 66 Inc. Nasdaq IMGN 66 ® bortezomib 66 MKC# 66 Inc Therapeutic Competitors 66 Receives Orphan Drug Designation 66 Panzem R 66 Presents Positive 66 leading lipid nanoparticle 66 peripherally acting 66 proteasome inhibitor 66 Vytorin combines 66 low toxicity bioscience 66 Inhalation Powder 66 PDL BioPharma logo 65 please visit http:/www.supergen.com 65 based pretargeting methods 65 developing Zerenex TM 65 phenylketonuria PKU developed 65 Exelixis logo 65 fibrosis IPF 65 Advancing Drugs 65 Inc. Nasdaq NEXM 65 PEG PAL PEGylated recombinant 65 gel formulations 65 unique PER.C6 ® 65 Medarex logo 65 stable nucleic acid 65 R bortezomib 65 phenylalanine ammonia lyase 65 neuro inflammatory 64 BiTE R 64 Onalta 64 Methylnaltrexone 64 HepeX B 64 FDA Accepts 64 gets USFDA nod 64 inflammatory autoimmune diseases 64 Meets Primary Endpoint 64 Enrolls First 64 Sodium oxybate 64 treat male hypogonadism 64 Kuvan R 64 pramlintide acetate injection 64 regarding Aethlon Medical 64 Cerus Corporation 64 ZymoGenetics intends 64 GVAX cancer 64 Inc. NASDAQ TRGT 64 Lipid Polymer Micelle LPM 64 BiovaxID TM 64 refractory chronic lymphocytic 64 Locteron ® 64 Potassium Chloride Sodium Ascorbate 64 system vaporizes unformulated 64 SNALP technology 64 New Chemical Entities 64 aesthetic medicine BioLook 64 pancreatic enzyme replacement 64 novel anti infective 64 Idera Pharmaceuticals 64 ALN PCS 64 www.vivus.com 64 Therapeutic Competitors 64 nitric oxide donating 64 Copegus R 63 AeroLEF R 63 Belimumab 63 TELINTRA 63 MassARRAY R 63 candidate Zenvia 63 Biomagnetics Diagnostics Corporation 63 www.nymox.com email info@nymox.com 63 Recombinant Human 63 ankylosing spondylitis psoriatic arthritis 63 optical biosensors 63 BYETTA ® 63 eligen R technology 63 Amgen discovers develops 63 REGN# 63 www.biodel.com 63 Inhalation Aerosol 63 Inc. Nasdaq ELGX 63 staphylococcal vaccines